TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Antiretrovirals
Research reports on antiretrovirals from A. Kiboneka and colleagues provide new insights
April 7th, 2009
According to recent research from Vancouver, Canada, " To measure the clinical and immunological outcomes of HIV positive adult patients receiving combination antiretroviral therapy in conflict affected northern Uganda. Prospective cohort study." " Gulu District, northern Uganda. Participants 1625 adults (aged over 14 years) receiving combination antiretroviral therapy. Main outcome measures Primary outcome: all cause mortality. impact of covariates (sex, age, CD4 count at start, adherence, tuberculosis at start, duration of treatment, and internally displaced person status) on mortality. Sixty nine (4.2%) patients died during follow-up. The mortality incidence rate...
Source: TB & Outbreaks Week (2009-04-07)
|
